Kidney transplant recipients do not produce as robust an antibody response to COVID-19 vaccines as healthy individuals

A preprint, not yet peer-reviewed, CITF-funded study found that only 45% of kidney transplant recipients (KTRs) developed Omicron-specific neutralizing antibodies one month following a third vaccine dose.